UC DAVIS FAILS TO WIN $59 MILLION GRANT
16 Sep 2003
Source: Sacramento Bee, September 4, 2003
UC Davis fails to win $59 million grant that would have helped fund bio lab
University officials 'stunned'
By Pamela Martineau -- Bee Staff Writer
UC Davis' bid for a proposed bio lab suffered a crushing setback Thursday when federal officials denied the university funding for a critical research consortium that would have operated out of its proposed facility.
Officials with the U.S. Department of Health and Human Services named eight institutions that will receive five-year grants to operate Regional Centers of Excellence where scientists would study infectious diseases and defenses against bioterrorist attacks. UC Davis was not among the grant recipients.
"We're pretty stunned," said Lynne Chronister, associate vice chancellor for research administration.
She and other campus officials had envisioned the $59 million federal grant as a key component in the operation of the university's proposed National Biocontainment Laboratory.
If the National Institutes of Health were to fund the bio lab, the research consortium would have been headquartered within it, providing a large share of the lab's ongoing research money.
Chronister said that if the university were still to receive funding for a bio lab, officials would need to establish a collaboration with another institution that was awarded one of Thursday's grants. The only institution on the West Coast awarded funding was the University of Washington.
"We would definitely need to seek other sources of research support and we would have to work with one of the existing RCEs," she said.
UC Davis' application said it would be working with scientists from universities throughout the West - including those from Stanford University, the University of California at Los Angeles, Lawrence Livermore lab, and the California Department of Health Services. They would have conducted research for the regional center at various locations in the state. They would have used the proposed biolab to test dangerous pathogens that require the Bio Safety Level 4 security.
The Regional Centers of Excellence are envisioned by federal officials as a national research network to bolster the country's defenses against diseases, whether they are naturally occurring or the result of bioterrorism. The federal health services department announced $350 million Thursday for the five year grants.
Officials from other institutions that received the Regional Centers of Excellence grants said they believed an applicant for a bio lab must have an existing, established collaboration with an RCE in order to remain in the running for bio lab funding.
"If we hadn't gotten an RCE we wouldn't be in contention (for a bio lab)," said Tom Curtis, a spokesman for the University of Texas Medical Branch at Galveston.
"The RCE designation is a prerequisite for institutions to be considered for an NBL," John D. Soto, president of UTMB said in a prepared statement announcing the university's award.
Officials within the NIH declined to comment on what impact the loss of an RCE award would have on an application for a bio lab, saying the final decisions on the bio lab funding have not been made.
UC Davis is vying with at least five other institutions in the nation for $140 million to build a 285,000 square foot national biocontainment laboratory. In the lab, scientists would study some of the world's most dangerous diseases including Ebola, plague and anthrax.
The NIH is expected to announce the funding grants for two such labs later this month.
Of the six known institutions vying for the lab, three received funding for Regional Centers of Excellence: They are: the New York State Department of Health, UTMB and the University of Illinois at Chicago, which applied for an RCE in conjunction with the University of Chicago and other local institutions.
The bio lab proposal has sparked significant controversy in the city of Davis where more than 150 opponents have packed city hall for briefings on the issue on several occasions. Most opponents say they fear the lab could become the target of terrorists and could spread dangerous pathogens through the community through accidents or safety breaches. Marches and silent protests also have been staged to oppose the project.
In February, the Davis City Council voted unanimously to oppose the lab, saying it was too divisive.
A handful of supporters of the lab also have spoken at public meetings and about 25 proponents held a rally in support of the project when officials from the NIH visited the campus in July.
Dick Bakker, a Davis resident who supports the lab, said he was disappointed, but hoped UC Davis could still move forward with its bio lab proposal.
"I'm certain that UCD is able to handle the lab and all the intricacies of the lab," Bakker said. "They already have ongoing research up to biosafety level 3 on campus."
Don Mooney, an attorney for the group, Stop UCD Bio Lab Now, said he has read the NIH's request for proposals for the NBL thoroughly and he believes UC Davis's loss of the RCE "should be the end" of the biolab proposal. Davis City Councilman Mike Harrington agreed.
"There was funding for the tenant and funding for the facility and they've lost the funding for the tenant," said Harrington. "UCD should do the right thing and pull their application now to demonstrate their good will to the community."
Other institutions that were awarded RCE grants are: Duke University; Harvard Medical School; University of Maryland, Baltimore and Washington University in St. Louis. The University of Iowa and the University of Minnesota received planning grants that could lead to the establishment of regional research centers.